Skip to main content

Research Repository

Advanced Search

MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness Mar 1, 2019 - Feb 29, 2024
A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with c... Read More about MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness.

Adapting a smartphone-based rehabilitation programme for older adults living with and beyond cancer: an intervention development study Apr 1, 2022 - Sep 30, 2023
The number of people living with and beyond cancer is growing; many are over 65 years old who often have different and more complicated healthcare needs than younger people.

Being active is one of the best things people with, or who ha... Read More about Adapting a smartphone-based rehabilitation programme for older adults living with and beyond cancer: an intervention development study.

Evaluating the effectiveness and acceptability of free door to door transport to increase the uptake of breast screening appointments in Yorkshire: A cluster randomised GP pilot trial Jun 1, 2023 - Jul 31, 2025
Breast screening is one of the key tools in identifying breast cancer at an early stage. It is currently offered to women between the ages of 50 and 70 on a three yearly cycle. Whilst nationally breast screening uptake is 70% this leaves 30% of wom... Read More about Evaluating the effectiveness and acceptability of free door to door transport to increase the uptake of breast screening appointments in Yorkshire: A cluster randomised GP pilot trial.

REMEDI4ALL BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL Sep 1, 2022 - Aug 31, 2027
Osteogenesis imperfecta (OI) causes skeletal fragility, bone pain, sarcopenia and reduced connective tissue resilience, shown as hypermobility and aortic root dilatation (in adults). There is no effective treatment for OI. Current agents only target... Read More about REMEDI4ALL BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL.